Journal of Clinical Oncology , ‎0732-183X

Journal

1 - 10 out of 121Page size: 10

Publications

  1. 2021
  2. E-pub ahead of print

    Reply to G. Gui et al

    Aimee Jackson & Sylvie Freeman, 5 May 2021, (E-pub ahead of print) In: Journal of Clinical Oncology.

    Research output: Contribution to journal › Comment/debate › peer-review

  3. 2020
  4. E-pub ahead of print

    Augmented reduced-intensity regimen does not improve postallogeneic transplant outcomes in acute myeloid leukemia

    Charles Craddock, Aimee Jackson, Justin Loke, Ram Malladi, Keith Wheatley & 7 others, , , , , Naeem Khan, & Sylvie Freeman, 29 Dec 2020, (E-pub ahead of print) In: Journal of Clinical Oncology . 12 p., JCO2002308.

    Research output: Contribution to journal › Article › peer-review

  5. E-pub ahead of print

    Defining the Optimal Total Number of Chemotherapy Courses in Younger Patients With Acute Myeloid Leukemia: A Comparison of Three Versus Four Courses

    Sylvie Freeman, , , , , , , & , 23 Dec 2020, (E-pub ahead of print) In: Journal of Clinical Oncology . p. JCO2001170

    Research output: Contribution to journal › Article › peer-review

  6. E-pub ahead of print

    Elective cancer surgery in COVID-19–free surgical pathways during the SARS-CoV-2 pandemic: an international, multicenter, comparative cohort study

    Aneel Bhangu, 6 Oct 2020, (E-pub ahead of print) In: Journal of Clinical Oncology . 14 p., JCO2001933.

    Research output: Contribution to journal › Article › peer-review

  7. Published

    De-escalation after DE-ESCALATE and RTOG 1016: a head and neck cancer InterGroup framework for future de-escalation studies

    Hisham Mehanna, , , , , , , , , , , , & , 1 Aug 2020, In: Journal of Clinical Oncology . 38, 22, p. 2552-2557 7 p.

    Research output: Contribution to journal › Article › peer-review

  8. E-pub ahead of print

    Overestimation of Late Distant Recurrences in High-Risk Patients With ER-Positive Breast Cancer: Validity and Accuracy of the CTS5 Risk Score in the TEAM and IDEAL Trials

    Daniel Rea, , , , , , , , & , 24 Jul 2020, (E-pub ahead of print) In: Journal of Clinical Oncology . p. JCO1902427

    Research output: Contribution to journal › Article › peer-review

  9. Published

    Less is not necessarily more: toward a rational selection of the conditioning regimen in acute myeloid leukemia

    Sylvie Freeman & , 20 Apr 2020, In: Journal of Clinical Oncology . 38, 12, p. 1249-1251 3 p.

    Research output: Contribution to journal › Editorial

  10. Published

    ARISTOTLE: A phase III trial comparing concurrent capecitabine with capecitabine and irinotecan (Ir) chemoradiation as preoperative treatment for MRI-defined locally advanced rectal cancer (LARC).

    Simon Bach, 2020, In: Journal of Clinical Oncology . p. 4101-410 9 p.

    Research output: Contribution to journal › Article › peer-review

  11. 2019
  12. Published

    Ibrutinib plus venetoclax in relapsed/refractory chronic lymphocytic leukemia: the CLARITY study

    Kristian Brock, Sam Munoz Vicente, , , Becky Boucher, , , , , , , , , , , & , 20 Oct 2019, In: Journal of Clinical Oncology . 37, 30, p. 2722-2729 8 p.

    Research output: Contribution to journal › Article › peer-review

  13. Published

    Trans-aTTom: Breast Cancer Index for prediction of endocrine benefit and late distant recurrence (DR) in patients with HR+ breast cancer treated in the adjuvant tamoxifen—To offer more? (aTTom) trial.

    Ikhlaaq Ahmed, , , Sarah Pirrie, & Daniel Rea, 20 May 2019, In: Journal of Clinical Oncology. 37, 15_suppl, p. 505 1 p.

    Research output: Contribution to journal › Abstract › peer-review

Previous 1 2 3 4 5 6 7 8 ...13 Next